116 related articles for article (PubMed ID: 32178834)
21. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
Lin L; Gu ZT; Chen WH; Cao KJ
Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
[TBL] [Abstract][Full Text] [Related]
22. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA
Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
[TBL] [Abstract][Full Text] [Related]
23. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
Yan B; Zhang W; Mao XW; Jiang LY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
[TBL] [Abstract][Full Text] [Related]
25. A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer.
Lin T; Fu Y; Zhang X; Gu J; Ma X; Miao R; Xiang X; Niu W; Qu K; Liu C; Wu Q
Aging (Albany NY); 2018 Sep; 10(9):2356-2366. PubMed ID: 30205363
[TBL] [Abstract][Full Text] [Related]
26. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNAs are spatially correlated with transcription factors and regulate lung development.
Herriges MJ; Swarr DT; Morley MP; Rathi KS; Peng T; Stewart KM; Morrisey EE
Genes Dev; 2014 Jun; 28(12):1363-79. PubMed ID: 24939938
[TBL] [Abstract][Full Text] [Related]
28. [Expression of FATS in non-small cell lung cancer and its relationship with prognosis].
Zhang TM; Zhang J; Zhou DJ; Wang CL
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):826-830. PubMed ID: 31770849
[No Abstract] [Full Text] [Related]
29. CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.
Si J; Zhang P; Tian D; Wang X; Ma Y; Zhang J; Wang L; Yang Y
World J Surg Oncol; 2017 Jan; 15(1):34. PubMed ID: 28129775
[TBL] [Abstract][Full Text] [Related]
30. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
31. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
Deng J; Liang Y; Liu C; He S; Wang S
Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
[TBL] [Abstract][Full Text] [Related]
32. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: Evidence from the GEO database.
Zhang Z; Liu T; Wang K; Qu X; Pang Z; Liu S; Liu Q; Du J
Gene; 2017 Sep; 630():49-58. PubMed ID: 28782577
[TBL] [Abstract][Full Text] [Related]
34. Effect of epidermal growth factor receptor mutation on early-stage non-small cell lung cancer according to the 8th TNM classification.
Isaka T; Ito H; Nakayama H; Yokose T; Yamada K; Masuda M
Lung Cancer; 2020 Jul; 145():111-118. PubMed ID: 32428800
[TBL] [Abstract][Full Text] [Related]
35. Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression and poor prognosis in patients with non-small cell lung cancer.
Zhao QS; Li L; Zhang L; Meng XW; Li LL; Ge XF; Li ZP
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3031-4. PubMed ID: 27460731
[TBL] [Abstract][Full Text] [Related]
36. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.
Liu XH; Liu ZL; Sun M; Liu J; Wang ZX; De W
BMC Cancer; 2013 Oct; 13():464. PubMed ID: 24103700
[TBL] [Abstract][Full Text] [Related]
37. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Long Non-Coding RNA Expression Profiles in Non-Small Cell Lung Cancer.
Wang L; Chen Z; An L; Wang Y; Zhang Z; Guo Y; Liu C
Cell Physiol Biochem; 2016; 38(6):2389-400. PubMed ID: 27299310
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer.
Tian Y; Feng Y
Cancer Biomark; 2018; 22(4):781-785. PubMed ID: 29843223
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
